Introduction should be applicable to drugs used in any speciality, and to drugs currently available as well as to those yet to be The General Medical Council (GMC) has repeatedly called for changes to traditional medical school curricula which developed. were considered to be overburdened with factual material and to often emphasise teaching rather than learning. The Implementation of the core content GMC published recommendations [1] for the development The pattern of courses will differ in different medical of new medical curricula, which should take the form of a schools, and this work does not attempt to define how core curriculum, mandatory for all students and occupying any individual school should ensure that these issues are about two thirds of the course, and special study modules, learned. In general, the curriculum is confined to those occupying about one third of the course, for which the areas in which the learning is best directed by clinical student should be offered a range of options for study in pharmacologists and unlikely to be adequately directed by depth. The new curricula should emphasise learning by the other specialists. student, partly self directed and partly faculty directed.
This work does not address the learning of the clinical The core curriculum itself was only broadly defined by pharmacology of commonly used drugs nor the therapeutics the GMC, which argued that curricula should not be of major clinical problems or medical emergencies. This speciality or departmentally based but should be integrated learning is of major importance and should ideally be both horizontally and vertically, i.e. with true interdisciplindirected by clinical pharmacologists. Recognising that there ary synthesis rather than just co-ordination. The GMC did is a shortage of clinical pharmacologists to take on this not have the resources to define the core content of all workload, many medical schools will opt to use specialists subjects even if this were desirable, but indicated that it in individual medical specialities for this task, but at the very would promote the definition of core content for specific least clinical pharmacologists should be involved in defining subjects by other organisations who might be concerned to the content of this element of the course and in its improve undergraduate education in that area. Such course co-ordination. definitions could then be made widely available so that they
The curriculum in clinical pharmacology should be could be adopted by any medical school, with appropriate learned as a continuum throughout the medical school local modifications.
course, starting with more basic pharmacology but with In this spirit, the committee of the Clinical Section of some content of clinical pharmacology and therapeutics, and the British Pharmacological Society proposed to develop a gradually moving to a more clinically based course with core content for courses in clinical pharmacology and greater emphasis on clinical pharmacology and therapeutics, therapeutics. This core content was developed from an while retaining links to basic pharmacology. Finally, the American model [2] by academic clinical pharmacologists skills and attitudes introduced to undergraduates should be with experience in undergraduate learning, using a Delphi refined during the preregistration house officer year which technique [3] . The following document is the result of is also the responsibility of the university. this work.
This course should be closely integrated with the other subjects under study by the students, or in more problemAim based courses, incorporated as a vital part of each problem area. The curriculum should ideally be learned in small The purpose of the work was to identify what should amounts over the full medical course, building on what was constitute the core content of courses in clinical pharmapreviously learnt and with key points frequently recurring; cology and therapeutics, i.e. the knowledge, skills and some schools may in addition want to have a discrete section attitudes that medical students should learn in order to or sections devoted predominantly to clinical pharmacology become competent to prescribe drugs safely and effectively and therapeutics at one specific time. and to maintain this competence throughout their professional lives. The approach and understanding of optimal Assessment Any core curriculum must be tested rigorously. Assessment of the course content here should be progressive, are more difficult to assess. Its ultimate test will be the toxicity; this should be illustrated using common clinical examples. testing of competency to prescribe effectively and safely, which is the measure of a cluster of skills, knowledge and attitudes. The assessment of the general approach to 7 Prescribing for paediatric patients Students should understand the principles of prescribing for paediatric patients, 'learning' as opposed to 'teaching' is also important but difficult; this assessment would depend on measuring the including differences in pharmacokinetics and pharmacodynamics compared with adults. motivation of students and their ability to learn in the future rather than their factual knowledge at a given point.
8 Prescribing for the elderly Students should understand the special problems in prescribing for the elderly, including Core content altered physiology, pharmacokinetics and pharmacodynamics, and in particular the special problems caused in the In keeping with the format described by the GMC, the core content is divided into areas of a) core knowledge and elderly by polypharmacy. understanding, b) skills, and c) attitudes, that students should acquire or develop.
9 Principles of prescribing for pregnant and breast-feeding women Students should understand the special concerns for drug toxicity to mother, fetus, and nursing infant. Students a) Core knowledge and understanding should also know the drugs of choice in disease states common in pregnant and breast-feeding women. 1 Basics of pharmacology Students should understand the mechanisms by which drugs produce their pharmacological effects. They should appreciate the links between pharmaco-10 Prescribing for patients with renal disease Students should understand the problems associated with prescribing for logical effects at the molecular level, the cellular level, and the tissue/organ level, and how these effects can be disrupted patients with renal disease, including altered pharmacokinetics, especially renal excretion; altered pharmacodynamby disease processes and other drugs. Hence they should understand the principles through which therapeutic and ics; the drugs to be avoided in patients with renal disease; and drug-induced nephrotoxicity. adverse effects occur.
Clinical pharmacokinetics Students should understand
11 Prescribing for patients with hepatic disease Students should understand the problems associated with prescribing how drugs are absorbed, distributed, and cleared by biotransformation and/or excretion. They should understand for patients with hepatic disease, including altered pharmacokinetics, especially biotransformation; altered pharmacodynthe concepts of drug half-life and clearance. (Application to clinical situations should be emphasised and detailed calcuamics; the drugs to be avoided in patients with hepatic disease; and drug-induced hepatotoxicity. lations avoided). Students should understand 12 General approach to the treatment of the poisoned patient Students should understand the principles of managing how to monitor drug therapy by observing and recording therapeutic responses directly, or indirectly by measuring patients who have been poisoned by drugs or other toxic substances, including how to assess such patients and how pharmacodynamic responses or plasma drug concentrations. They should understand the scientific basis for measuring to recognise common presenting syndromes; how to remove the toxic substances, including decontamination and proplasma drug concentrations. They should understand that interindividual variations in response to drugs limit the value cedures to increase drug clearance; the use of antidotes where appropriate; and the specific management of comof a therapeutic range for drug concentrations. The basic principles should be emphasised and their relevance to mon poisonings (e.g. aspirin, paracetamol and tricyclic antidepressants). clinical practice illustrated by concentrating on clinically important examples.
Monitoring drug therapy
13 Regulations affecting prescribing Students should know the national regulations concerning the availability and use 4 Adverse drug reactions Students should understand the epidemiology of adverse drug reactions and how to of drugs and in particular those affecting controlled drugs (e.g. opiates etc.); British National Formulary guidelines on recognise and avoid them. They should understand the importance of reporting adverse drug reactions and the prescription writing; and regulations concerning the use of experimental therapies or established therapies for experyellow card scheme.
imental purposes. Students should understand the role of local formularies and drug and therapeutics committees.
Drug interactions
Students should understand the epidemiology of adverse drug interactions. They should understand the mechanisms by which interactions may occur 14 The process of new drug development, testing and approval Students should understand pre-clinical development and so that they may predict them and understand how to avoid them.
testing; testing in Phase I (human pharmacology), II (therapeutic exploratory) and III (therapeutic confirmatory); the essential elements of a good clinical trial; the need for 6 Pharmacogenetics Students should understand the principles of pharmacogenetics and its importance in determining informed consent and ethical approval in clinical research; the role of the Committee on Safety of Medicines and variation in response to drugs in terms of efficacy and European agencies; the importance of phase IV (therapeutic effects of a given drug. Students should know for which drugs to request measurement of drug concentrations and use) studies for drug safety and for the development of new indications.
when it is appropriate; they should be aware of the principles of how to adjust therapeutic regimens in the light of results.
Practical criteria for selecting among drugs in a therapeutic class Students should understand the practical criteria for
7 Prescribing for the elderly Students should be able to selecting among drugs in a therapeutic class, including recognise and avoid drugs that pose special problems and differences in pharmacokinetics or pharmacodynamics;
risks for elderly patients and should understand the characterapproved indications; possible adverse effects or drug istics of drugs which require modification of dosage in interactions; and cost effectiveness. elderly patients. clinical trials or reviews or as promotional material. This 3 Drug allergy Students should become skilled at includes understanding the need to consider real clinical recognising and treating the most common presentations of end-points as opposed to surrogate end-points wherever allergic responses to drugs; know the correct approach to possible, the basics of clinical trial design and conduct, and managing a patient with an acute anaphylactic reaction; and the basics of medical statistics. Students should begin to should be able to take a history of drug use, including develop skill in reading and assessing scientific papers history of medication allergy or intolerance.
Routes of administration and drug formulations
describing clinical trials, and in distinguishing valid studies from those with serious methodological flaws or bias. They 4 Drug interactions Students should become skilled in should learn to use properly evaluated evidence as the recognising common drug interactions. It is equally importscientific basis of their clinical practice whenever possible. ant that they should be skilled in using common reference materials to ascertain potential drug interactions with the 12 Learning about new drugs Students should be familiar drugs they will be prescribing in order to avoid unintended with sources of accurate information concerning new drugs and unexpected drug interactions; when interacting drugs and their appropriate use. All students should know how to must be prescribed, students should be familiar with use sources of objective information about current and new approaches to optimal prescribing in order to minimise toxic drugs. Students should learn how to use available reference interactions.
texts, library resources, computer data-bases (e.g. Medline) and objective newsletters (e.g. Drug and Therapeutics 5 Seeking information Students should develop the ability Bulletin) to carry out their own programmes of continuing to use reference sources, including the British National education concerning developments in drug use. Formulary, other reference texts, original research literature and drug information services, to find information on aspects 13 Communication skills Students should become able to of drug therapy with which they are unfamiliar for specific talk with patients to elicit a complete drug history, including patients or indications. Students should be able to use prescription and non-prescription drugs, and to ascertain common reference sources and Poisons Centres for rapidly previous adverse drug reactions and drug allergies. Students obtaining accurate information about the diagnosis and should know how to use the various written materials that treatment of acute poisoning.
are available as patient inserts. They should have an understanding of the nature of informed consent and how it 6 Therapeutic drug monitoring Students should understand what therapeutic effect to observe in order to monitor the applies to drug use.
14 Patient adherence to therapy Students should understand 3 The prescription as an experiment Students should develop the attitude that every prescription is really a that patients may not adhere to prescribed drugs and why this may occur. They should learn to assess the degree of carefully designed experiment that can produce a useful clinical effect, toxicity, or both. They should learn how to nonadherence, and consider nonadherence as a possible cause of therapeutic failure. They should learn to encourage choose appropriate drugs for appropriate indications and appropriate patients, and how to individualise therapy in adherence by the use of simple drug regimens and by ensuring that the patient understands and agrees the aims of specific cases. They should be aware of the implications of individual variation in responses to drugs and should the treatment, as well as the proper manner in which to use the prescribed drugs.
understand the benefits and limitations of applying data from clinical trials to the individual. They should learn to observe the results of their prescribing systematically and review c) Core Attitudes their prescribing in the light of these outcomes.
1 The process of optimal therapeutics Students should be 4 Learning for the future Students should understand that accustomed to proceeding through a logical sequence of therapeutics as currently practised will be modified by future deliberate steps before prescribing. They should attempt to medical advances, and that it is their professional duty to make a firm diagnosis; understand the pathophysiology of adapt to changes and to keep up to date with such advances the disease they have identified; list possible treatments and so that their patients may benefit accordingly. They must select the most appropriate, given the features of the understand that new therapies often bring new risks as well particular patient; establish what end-points to follow; and as benefits, and must learn to weigh the potential benefits communicate adequately with the patient concerning goals, of new therapies against their possible hazards, even where risks, and appropriate follow-up. Developing such an optimal these hazards are as yet unrecognised. Students should also therapeutic plan depends on the ability of the student to learn the limitations of their own knowledge and be ready assess and estimate the potential risks and benefits of using a to use reference sources or seek advice when necessary. drug in a specific patient.
Balanced approach to drug prescribing Students should
References understand the balance that must be struck between benefit 1 General Medical Council. Tomorrow's Doctors, London and risk in deciding to use drug therapy and that this balance learn to avoid wasteful and unnecessary prescribing.
